US FDA approves Citius blood cancer therapy
The U.S. Food and Drug Administration has approved Citius Pharmaceuticals The company said Thursday that its blood cancer drug Lymphir is for patients with a relapse who have received at least one prior treatment.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO